BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30087366)

  • 21. Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer.
    Yoshimoto N; Toyama T; Takahashi S; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
    Breast Cancer Res Treat; 2011 Nov; 130(1):331-9. PubMed ID: 21755340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8.
    Hu N; Zhang J; Cui W; Kong G; Zhang S; Yue L; Bai X; Zhang Z; Zhang W; Zhang X; Ye L
    J Biol Chem; 2011 Apr; 286(15):13714-22. PubMed ID: 21343296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
    Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
    J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer.
    Hui Z; Yiling C; Wenting Y; XuQun H; ChuanYi Z; Hui L
    FEBS Lett; 2015 Mar; 589(7):812-21. PubMed ID: 25725194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant expression of SETD1A promotes survival and migration of estrogen receptor α-positive breast cancer cells.
    Jin ML; Kim YW; Jin HL; Kang H; Lee EK; Stallcup MR; Jeong KW
    Int J Cancer; 2018 Dec; 143(11):2871-2883. PubMed ID: 30191958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GSE1 negative regulation by miR-489-5p promotes breast cancer cell proliferation and invasion.
    Chai P; Tian J; Zhao D; Zhang H; Cui J; Ding K; Liu B
    Biochem Biophys Res Commun; 2016 Feb; 471(1):123-8. PubMed ID: 26828271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.
    Stinson S; Lackner MR; Adai AT; Yu N; Kim HJ; O'Brien C; Spoerke J; Jhunjhunwala S; Boyd Z; Januario T; Newman RJ; Yue P; Bourgon R; Modrusan Z; Stern HM; Warming S; de Sauvage FJ; Amler L; Yeh RF; Dornan D
    Sci Signal; 2011 Aug; 4(186):pt5. PubMed ID: 21868360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of circFNDC3B promotes the progression of oral tongue squamous cell carcinoma through the miR-1322/MED1 axis.
    Chen X; Kong D; Deng J; Mo F; Liang J
    Head Neck; 2022 Nov; 44(11):2417-2427. PubMed ID: 35916453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2.
    Zhang Y; Xu G; Liu G; Ye Y; Zhang C; Fan C; Wang H; Cai H; Xiao R; Huang Z; Luo Q
    Biochem Biophys Res Commun; 2016 Aug; 476(4):607-613. PubMed ID: 27264952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LINC00461 promotes cell migration and invasion in breast cancer through miR-30a-5p/integrin β3 axis.
    Dong L; Qian J; Chen F; Fan Y; Long J
    J Cell Biochem; 2019 Apr; 120(4):4851-4862. PubMed ID: 30623482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
    Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
    Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
    [No Abstract]   [Full Text] [Related]  

  • 32. MiR-30a-5p/UBE3C axis regulates breast cancer cell proliferation and migration.
    Xiong J; Wei B; Ye Q; Liu W
    Biochem Biophys Res Commun; 2019 Aug; 516(3):1013-1018. PubMed ID: 27003255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-335 suppresses the proliferation, migration, and invasion of breast cancer cells by targeting EphA4.
    Dong Y; Liu Y; Jiang A; Li R; Yin M; Wang Y
    Mol Cell Biochem; 2018 Feb; 439(1-2):95-104. PubMed ID: 28795314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancer.
    Kim YS; Park SJ; Lee YS; Kong HK; Park JH
    Oncotarget; 2016 Jul; 7(27):42261-42273. PubMed ID: 27304060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA 362-3p Reduces hERG-related Current and Inhibits Breast Cancer Cells Proliferation.
    Assiri AA; Mourad N; Shao M; Kiel P; Liu W; Skaar TC; Overholser BR
    Cancer Genomics Proteomics; 2019; 16(6):433-442. PubMed ID: 31659098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen receptor α promotes protein synthesis by fine-tuning the expression of the eukaryotic translation initiation factor 3 subunit f (eIF3f).
    Cuesta R; Berman AY; Alayev A; Holz MK
    J Biol Chem; 2019 Feb; 294(7):2267-2278. PubMed ID: 30573685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling.
    Zeng Y; Gao T; Huang W; Yang Y; Qiu R; Hou Y; Yu W; Leng S; Feng D; Liu W; Teng X; Yu H; Wang Y
    J Biol Chem; 2019 Oct; 294(43):15808-15825. PubMed ID: 31492753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3.
    Muhammad N; Bhattacharya S; Steele R; Ray RB
    Oncotarget; 2016 Sep; 7(36):58595-58605. PubMed ID: 27517632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1.
    Zhang ZG; Chen WX; Wu YH; Liang HF; Zhang BX
    Biochem Biophys Res Commun; 2014 Nov; 454(1):109-14. PubMed ID: 25450365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
    Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
    Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.